 | Up a level |
Journal Article
Moesges, R., Bachert, C., Panzner, P., Calderon, M. A., Haazen, L., Pirotton, S., Wathelet, N., Durham, S. R., Bonny, M. -A., Legon, T., von Frenckell, R., Pfaar, O. and Shamji, M. H. (2018). Short course of grass allergen peptides immunotherapy over 3weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial. Allergy, 73 (9). S. 1842 - 1851. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah-Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G. and Shamji, M. H. (2018). A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy. Allergy, 73 (4). S. 896 - 905. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Koch, A. F., Raskopf, E., Singh, J., Shah-Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R. and Shamji, M. H. (2018). Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients. Allergy, 73 (6). S. 1254 - 1263. HOBOKEN: WILEY. ISSN 1398-9995
Shamji, M. H., Kasche, E. M., Zadoyan, G., Astvatsourov, A., Durham, S. R., Pirotton, S., Legon, T. and Moesges, R. (2015). Hydrolyzed Lolium perenne peptide fragments administered subcutaneously to hay fever patients induce allergen-specific IgG(4) and blocking antibodies after two or more weeks of treatment. Allergy, 70. S. 631 - 633. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Zadoyan, G., Shah-Hosseini, K., Astvatsatourov, A., Sohlich, L., Kasche, Em E. M., Shamji, M. H., Durham, S. R., Pirotton, S., Legon, T. and Moesges, R. (2015). A prospective, randomized, double-blind placebo-controlled multi-centre dose-finding study of 3 different regimens of gpASIT plus (TM) administered subcutaneously to adult patients with grass pollen-induced allergic rhinoconjunctivitis. Allergy, 70. S. 41 - 43. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995
Zadoyan, G., V, Allekotte, S., Shamji, M. H., Kasche, E. M., Singh, J., Astvatsatourov, A., Shah-Hosseini, K., Pirotton, S., Legon, T., Caplanusi, A., Durham, S. R. and Mosges, R. (2016). Immunological biomarker predict clinical effects in subcutaneous peptide allergen immunotherapy. Allergy, 71. S. 319 - 321. HOBOKEN: WILEY-BLACKWELL. ISSN 1398-9995